Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 306

1.

Sex and the kidneys: current understanding and research opportunities.

Bairey Merz CN, Dember LM, Ingelfinger JR, Vinson A, Neugarten J, Sandberg KL, Sullivan JC, Maric-Bilkan C, Rankin TL, Kimmel PL, Star RA; participants of the National Institute of Diabetes and Digestive and Kidney Diseases Workshop on “Sex and the Kidneys”.

Nat Rev Nephrol. 2019 Oct 4. doi: 10.1038/s41581-019-0208-6. [Epub ahead of print] Review.

PMID:
31586165
2.

Chronic kidney diseases in agricultural communities: report from a workshop.

Mendley SR, Levin A, Correa-Rotter R, Joubert BR, Whelan EA, Curwin B, Koritzinsky EH, Gaughan DM, Kimmel PL, Anand S, Ordunez P, Reveiz L, Rohlman DS, Scammell MK, Wright RO, Star RA.

Kidney Int. 2019 Aug 2. pii: S0085-2538(19)30781-1. doi: 10.1016/j.kint.2019.06.024. [Epub ahead of print]

PMID:
31563333
3.

Psychiatric Illness and Mortality in Hospitalized ESKD Dialysis Patients.

Kimmel PL, Fwu CW, Abbott KC, Moxey-Mims MM, Mendley S, Norton JM, Eggers PW.

Clin J Am Soc Nephrol. 2019 Sep 6;14(9):1363-1371. doi: 10.2215/CJN.14191218. Epub 2019 Aug 22.

PMID:
31439538
4.

Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions.

SPRINT MIND Investigators for the SPRINT Research Group, Nasrallah IM, Pajewski NM, Auchus AP, Chelune G, Cheung AK, Cleveland ML, Coker LH, Crowe MG, Cushman WC, Cutler JA, Davatzikos C, Desiderio L, Doshi J, Erus G, Fine LJ, Gaussoin SA, Harris D, Johnson KC, Kimmel PL, Kurella Tamura M, Launer LJ, Lerner AJ, Lewis CE, Martindale-Adams J, Moy CS, Nichols LO, Oparil S, Ogrocki PK, Rahman M, Rapp SR, Reboussin DM, Rocco MV, Sachs BC, Sink KM, Still CH, Supiano MA, Snyder JK, Wadley VG, Walker J, Weiner DE, Whelton PK, Wilson VM, Woolard N, Wright JT Jr, Wright CB, Williamson JD, Bryan RN.

JAMA. 2019 Aug 13;322(6):524-534. doi: 10.1001/jama.2019.10551.

PMID:
31408137
5.

Epilepsy and antiseizure medications increase all-cause mortality in dialysis patients in the United States.

Waddy SP, Ward JB, Becerra AZ, Powers T, Fwu CW, Williams KL, Eggers PW, Abbott KC, Kimmel PL.

Kidney Int. 2019 May 16. pii: S0085-2538(19)30514-9. doi: 10.1016/j.kint.2019.04.033. [Epub ahead of print]

PMID:
31358345
6.

Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT.

Beddhu S, Shen J, Cheung AK, Kimmel PL, Chertow GM, Wei G, Boucher RE, Chonchol M, Arman F, Campbell RC, Contreras G, Dwyer JP, Freedman BI, Ix JH, Kirchner K, Papademetriou V, Pisoni R, Rocco MV, Whelton PK, Greene T.

J Am Soc Nephrol. 2019 Aug;30(8):1523-1533. doi: 10.1681/ASN.2018121261. Epub 2019 Jul 19.

PMID:
31324734
7.

Influence of prediabetes on the effects of intensive systolic blood pressure control on kidney events.

Rathi N, Whelton PK, Chertow GM, Cushman WC, Cheung AK, Wei G, Boucher R, Kimmel PL, Bress A, Kramer HJ, Al-Marji C, Greene T, Beddhu S.

Am J Hypertens. 2019 Jun 29. pii: hpz105. doi: 10.1093/ajh/hpz105. [Epub ahead of print]

PMID:
31257407
8.

Anxiety Symptoms in Patients Treated With Hemodialysis: Measurement and Meaning.

Kimmel PL, Cukor D.

Am J Kidney Dis. 2019 Aug;74(2):145-147. doi: 10.1053/j.ajkd.2019.04.012. Epub 2019 Jun 11. No abstract available.

PMID:
31200973
9.

Optimal management of HIV- positive adults at risk for kidney disease in Nigeria (Renal Risk Reduction "R3" Trial): protocol and study design.

Aliyu MH, Wudil UJ, Ingles DJ, Shepherd BE, Gong W, Musa BM, Muhammad H, Sani MU, Abdu A, Nalado AM, Atanda A, Ahonkhai AA, Ikizler TA, Winkler CA, Kopp JB, Kimmel PL, Wester CW.

Trials. 2019 Jun 10;20(1):341. doi: 10.1186/s13063-019-3436-y.

10.

How Community Engagement Is Enhancing NIDDK Research.

Kimmel PL, Jefferson N, Norton JM, Star RA.

Clin J Am Soc Nephrol. 2019 May 7;14(5):768-770. doi: 10.2215/CJN.14591218. Epub 2019 Mar 27. No abstract available.

PMID:
30917992
11.

Comparative Efficacy of Therapies for Treatment of Depression for Patients Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial.

Mehrotra R, Cukor D, Unruh M, Rue T, Heagerty P, Cohen SD, Dember LM, Diaz-Linhart Y, Dubovsky A, Greene T, Grote N, Kutner N, Trivedi MH, Quinn DK, Ver Halen N, Weisbord SD, Young BA, Kimmel PL, Hedayati SS.

Ann Intern Med. 2019 Mar 19;170(6):369-379. doi: 10.7326/M18-2229. Epub 2019 Feb 26.

PMID:
30802897
12.

Serum Metabolomic Alterations Associated with Proteinuria in CKD.

Luo S, Coresh J, Tin A, Rebholz CM, Appel LJ, Chen J, Vasan RS, Anderson AH, Feldman HI, Kimmel PL, Waikar SS, Köttgen A, Evans AM, Levey AS, Inker LA, Sarnak MJ, Grams ME; Chronic Kidney Disease Biomarkers Consortium Investigators.

Clin J Am Soc Nephrol. 2019 Mar 7;14(3):342-353. doi: 10.2215/CJN.10010818. Epub 2019 Feb 7.

PMID:
30733224
13.

Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial.

SPRINT MIND Investigators for the SPRINT Research Group, Williamson JD, Pajewski NM, Auchus AP, Bryan RN, Chelune G, Cheung AK, Cleveland ML, Coker LH, Crowe MG, Cushman WC, Cutler JA, Davatzikos C, Desiderio L, Erus G, Fine LJ, Gaussoin SA, Harris D, Hsieh MK, Johnson KC, Kimmel PL, Tamura MK, Launer LJ, Lerner AJ, Lewis CE, Martindale-Adams J, Moy CS, Nasrallah IM, Nichols LO, Oparil S, Ogrocki PK, Rahman M, Rapp SR, Reboussin DM, Rocco MV, Sachs BC, Sink KM, Still CH, Supiano MA, Snyder JK, Wadley VG, Walker J, Weiner DE, Whelton PK, Wilson VM, Woolard N, Wright JT Jr, Wright CB.

JAMA. 2019 Feb 12;321(6):553-561. doi: 10.1001/jama.2018.21442.

14.

Statistical methods for building better biomarkers of chronic kidney disease.

Pencina MJ, Parikh CR, Kimmel PL, Cook NR, Coresh J, Feldman HI, Foulkes A, Gimotty PA, Hsu CY, Lemley K, Song P, Wilkins K, Gossett DR, Xie Y, Star RA.

Stat Med. 2019 May 20;38(11):1903-1917. doi: 10.1002/sim.8091. Epub 2019 Jan 21.

PMID:
30663113
15.

Blood Pressure, Sexual Activity, and Erectile Function in Hypertensive Men: Baseline Findings from the Systolic Blood Pressure Intervention Trial (SPRINT).

Foy CG, Newman JC, Berlowitz DR, Russell LP, Kimmel PL, Wadley VG, Thomas HN, Lerner AJ, Riley WT; SPRINT Study Research Group.

J Sex Med. 2019 Feb;16(2):235-247. doi: 10.1016/j.jsxm.2018.12.007. Epub 2019 Jan 14.

PMID:
30655182
16.

Variability of Two Metabolomic Platforms in CKD.

Rhee EP, Waikar SS, Rebholz CM, Zheng Z, Perichon R, Clish CB, Evans AM, Avila J, Denburg MR, Anderson AH, Vasan RS, Feldman HI, Kimmel PL, Coresh J; CKD Biomarkers Consortium.

Clin J Am Soc Nephrol. 2019 Jan 7;14(1):40-48. doi: 10.2215/CJN.07070618. Epub 2018 Dec 20.

PMID:
30573658
17.

Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study.

Amdur RL, Feldman HI, Dominic EA, Anderson AH, Beddhu S, Rahman M, Wolf M, Reilly M, Ojo A, Townsend RR, Go AS, He J, Xie D, Thompson S, Budoff M, Kasner S, Kimmel PL, Kusek JW, Raj DS; CRIC Study Investigators.

Am J Kidney Dis. 2019 Mar;73(3):344-353. doi: 10.1053/j.ajkd.2018.09.012. Epub 2018 Dec 10.

18.

Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial.

Charytan DM, Himmelfarb J, Ikizler TA, Raj DS, Hsu JY, Landis JR, Anderson AH, Hung AM, Mehrotra R, Sharma S, Weiner DE, Williams M, DiCarli M, Skali H, Kimmel PL, Kliger AS, Dember LM; Hemodialysis Novel Therapies Consortium.

Kidney Int. 2019 Apr;95(4):973-982. doi: 10.1016/j.kint.2018.08.034. Epub 2018 Nov 23.

PMID:
30473139
19.

Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT.

Beddhu S, Chertow GM, Greene T, Whelton PK, Ambrosius WT, Cheung AK, Cutler J, Fine L, Boucher R, Wei G, Zhang C, Kramer H, Bress AP, Kimmel PL, Oparil S, Lewis CE, Rahman M, Cushman WC.

J Am Heart Assoc. 2018 Sep 18;7(18):e009326. doi: 10.1161/JAHA.118.009326.

20.

Urine inositol pentakisphosphate 2-kinase and changes in kidney structure in early diabetic kidney disease in type 1 diabetes.

Looker HC, Merchant ML, Rane MJ, Nelson RG, Kimmel PL, Rovin BH, Klein JB, Mauer M; CKD Biomarkers Consortium.

Am J Physiol Renal Physiol. 2018 Nov 1;315(5):F1484-F1492. doi: 10.1152/ajprenal.00183.2018. Epub 2018 Aug 22.

PMID:
30132343
21.

Biological Variability of Estimated GFR and Albuminuria in CKD.

Waikar SS, Rebholz CM, Zheng Z, Hurwitz S, Hsu CY, Feldman HI, Xie D, Liu KD, Mifflin TE, Eckfeldt JH, Kimmel PL, Vasan RS, Bonventre JV, Inker LA, Coresh J; Chronic Kidney Disease Biomarkers Consortium Investigators.

Am J Kidney Dis. 2018 Oct;72(4):538-546. doi: 10.1053/j.ajkd.2018.04.023. Epub 2018 Jul 18.

22.

Management of Nonadherence in ESKD Patients.

Cohen SD, Kimmel PL.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1080-1082. doi: 10.2215/CJN.13331117. Epub 2018 May 30. No abstract available.

23.

Kidney Diseases Associated with Human Immunodeficiency Virus Infection.

Cohen SD, Kopp JB, Kimmel PL.

N Engl J Med. 2018 Apr 26;378(17):1655-6. doi: 10.1056/NEJMc1800396. No abstract available.

PMID:
29694807
24.

Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials.

Beddhu S, Greene T, Boucher R, Cushman WC, Wei G, Stoddard G, Ix JH, Chonchol M, Kramer H, Cheung AK, Kimmel PL, Whelton PK, Chertow GM.

Lancet Diabetes Endocrinol. 2018 Jul;6(7):555-563. doi: 10.1016/S2213-8587(18)30099-8. Epub 2018 Apr 21.

25.

Treatment of Depression in CKD Patients with an SSRI: Why Things Don't Always Turn Out as You Expect.

Cukor D, Kimmel PL.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):943-945. doi: 10.2215/CJN.14421217. Epub 2018 Apr 13. No abstract available.

26.

Overcoming Translational Barriers in Acute Kidney Injury: A Report from an NIDDK Workshop.

Zuk A, Palevsky PM, Fried L, Harrell FE Jr, Khan S, McKay DB, Devey L, Chawla L, de Caestecker M, Kaufman JS, Thompson BT, Agarwal A, Greene T, Okusa MD, Bonventre JV, Dember LM, Liu KD, Humphreys BD, Gossett D, Xie Y, Norton JM, Kimmel PL, Star RA.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1113-1123. doi: 10.2215/CJN.06820617. Epub 2018 Mar 9.

27.

Benefits and risks of intensive blood-pressure lowering in advanced chronic kidney disease.

Cheung AK, Chertow GM, Greene T, Kimmel PL, Rahman M, Reboussin D, Rocco M; SPRINT Research Group.

J Intern Med. 2018 Jul;284(1):106-107. doi: 10.1111/joim.12735. Epub 2018 Mar 12. No abstract available.

PMID:
29385288
28.

Effect of Bariatric Surgery on CKD Risk.

Friedman AN, Wahed AS, Wang J, Courcoulas AP, Dakin G, Hinojosa MW, Kimmel PL, Mitchell JE, Pomp A, Pories WJ, Purnell JQ, le Roux C, Spaniolas K, Steffen KJ, Thirlby R, Wolfe B.

J Am Soc Nephrol. 2018 Apr;29(4):1289-1300. doi: 10.1681/ASN.2017060707. Epub 2018 Jan 15.

29.

Opioid Prescription, Morbidity, and Mortality in US Transplant Recipients.

Abbott KC, Fwu CW, Eggers PW, Eggers AW, Kline PP, Kimmel PL.

Transplantation. 2018 Jun;102(6):994-1004. doi: 10.1097/TP.0000000000002057.

30.

Kidney Diseases Associated with Human Immunodeficiency Virus Infection.

Cohen SD, Kopp JB, Kimmel PL.

N Engl J Med. 2017 Dec 14;377(24):2363-2374. doi: 10.1056/NEJMra1508467. Review. No abstract available. Erratum in: N Engl J Med. 2018 Apr 26; 378(17):1657.

PMID:
29236630
31.

Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT).

Rocco MV, Sink KM, Lovato LC, Wolfgram DF, Wiegmann TB, Wall BM, Umanath K, Rahbari-Oskoui F, Porter AC, Pisoni R, Lewis CE, Lewis JB, Lash JP, Katz LA, Hawfield AT, Haley WE, Freedman BI, Dwyer JP, Drawz PE, Dobre M, Cheung AK, Campbell RC, Bhatt U, Beddhu S, Kimmel PL, Reboussin DM, Chertow GM; SPRINT Research Group.

Am J Kidney Dis. 2018 Mar;71(3):352-361. doi: 10.1053/j.ajkd.2017.08.021. Epub 2017 Nov 20.

32.

Opioid Prescription, Morbidity, and Mortality in United States Dialysis Patients.

Kimmel PL, Fwu CW, Abbott KC, Eggers AW, Kline PP, Eggers PW.

J Am Soc Nephrol. 2017 Dec;28(12):3658-3670. doi: 10.1681/ASN.2017010098. Epub 2017 Sep 21.

33.

Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial.

Beddhu S, Rocco MV, Toto R, Craven TE, Greene T, Bhatt U, Cheung AK, Cohen D, Freedman BI, Hawfield AT, Killeen AA, Kimmel PL, Lash J, Papademetriou V, Rahman M, Rastogi A, Servilla K, Townsend RR, Wall B, Whelton PK; SPRINT Research Group.

Ann Intern Med. 2017 Sep 19;167(6):375-383. doi: 10.7326/M16-2966. Epub 2017 Sep 5.

PMID:
28869987
34.

Effect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes.

Berlowitz DR, Foy CG, Kazis LE, Bolin LP, Conroy MB, Fitzpatrick P, Gure TR, Kimmel PL, Kirchner K, Morisky DE, Newman J, Olney C, Oparil S, Pajewski NM, Powell J, Ramsey T, Simmons DL, Snyder J, Supiano MA, Weiner DE, Whittle J; SPRINT Research Group.

N Engl J Med. 2017 Aug 24;377(8):733-744. doi: 10.1056/NEJMoa1611179.

35.

APOL1 renal-risk variants do not associate with incident cardiovascular disease or mortality in the Systolic Blood Pressure Intervention Trial.

Freedman BI, Rocco MV, Bates JT, Chonchol M, Hawfield AT, Lash JP, Papademetriou V, Sedor JR, Servilla K, Kimmel PL, Wall BM, Pajewski NM; SPRINT Research Group.

Kidney Int Rep. 2017 Jul;2(4):713-720. doi: 10.1016/j.ekir.2017.03.008. Epub 2017 Mar 31.

36.

Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus.

Wheelock KM, Cai J, Looker HC, Merchant ML, Nelson RG, Fufaa GD, Weil EJ, Feldman HI, Vasan RS, Kimmel PL, Rovin BH, Mauer M, Klein JB; CKD Biomarkers Consortium.

PLoS One. 2017 Jul 10;12(7):e0180964. doi: 10.1371/journal.pone.0180964. eCollection 2017.

37.

Risk of ESRD and Mortality Associated With Change in Filtration Markers.

Rebholz CM, Inker LA, Chen Y, Liang M, Foster MC, Eckfeldt JH, Kimmel PL, Vasan RS, Feldman HI, Sarnak MJ, Hsu CY, Levey AS, Coresh J; Chronic Kidney Disease Biomarkers Consortium.

Am J Kidney Dis. 2017 Oct;70(4):551-560. doi: 10.1053/j.ajkd.2017.04.025. Epub 2017 Jun 23.

38.

Effects of Intensive BP Control in CKD.

Cheung AK, Rahman M, Reboussin DM, Craven TE, Greene T, Kimmel PL, Cushman WC, Hawfield AT, Johnson KC, Lewis CE, Oparil S, Rocco MV, Sink KM, Whelton PK, Wright JT Jr, Basile J, Beddhu S, Bhatt U, Chang TI, Chertow GM, Chonchol M, Freedman BI, Haley W, Ix JH, Katz LA, Killeen AA, Papademetriou V, Ricardo AC, Servilla K, Wall B, Wolfgram D, Yee J; SPRINT Research Group.

J Am Soc Nephrol. 2017 Sep;28(9):2812-2823. doi: 10.1681/ASN.2017020148. Epub 2017 Jun 22.

39.

Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT).

Weiner DE, Gaussoin SA, Nord J, Auchus AP, Chelune GJ, Chonchol M, Coker L, Haley WE, Killeen AA, Kimmel PL, Lerner AJ, Oparil S, Saklayen MG, Slinin YM, Wright CB, Williamson JD, Kurella Tamura M; SPRINT Study Research Group.

Am J Kidney Dis. 2017 Sep;70(3):357-367. doi: 10.1053/j.ajkd.2017.04.021. Epub 2017 Jun 9.

40.

Developing a neonatal acute kidney injury research definition: a report from the NIDDK neonatal AKI workshop.

Zappitelli M, Ambalavanan N, Askenazi DJ, Moxey-Mims MM, Kimmel PL, Star RA, Abitbol CL, Brophy PD, Hidalgo G, Hanna M, Morgan CM, Raju TNK, Ray P, Reyes-Bou Z, Roushdi A, Goldstein SL.

Pediatr Res. 2017 Oct;82(4):569-573. doi: 10.1038/pr.2017.136. Epub 2017 Jul 11. No abstract available.

PMID:
28604760
41.

Impact of Acute Kidney Injury in Patients Hospitalized With Pneumonia.

Chawla LS, Amdur RL, Faselis C, Li P, Kimmel PL, Palant CE.

Crit Care Med. 2017 Apr;45(4):600-606. doi: 10.1097/CCM.0000000000002245.

PMID:
28291091
42.

Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study.

Park M, Hsu CY, Go AS, Feldman HI, Xie D, Zhang X, Mifflin T, Waikar SS, Sabbisetti VS, Bonventre JV, Coresh J, Nelson RG, Kimmel PL, Kusek JW, Rahman M, Schelling JR, Vasan RS, Liu KD; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators; CKD Biomarkers Consortium.

Clin J Am Soc Nephrol. 2017 May 8;12(5):761-771. doi: 10.2215/CJN.08560816. Epub 2017 Mar 2.

43.

Patients receiving frequent hemodialysis have better health-related quality of life compared to patients receiving conventional hemodialysis.

Garg AX, Suri RS, Eggers P, Finkelstein FO, Greene T, Kimmel PL, Kliger AS, Larive B, Lindsay RM, Pierratos A, Unruh M, Chertow GM; Frequent Hemodialysis Network Trial Investigators.

Kidney Int. 2017 Mar;91(3):746-754. doi: 10.1016/j.kint.2016.10.033. Epub 2017 Jan 13.

44.

Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis.

Inker LA, Coresh J, Sang Y, Hsu CY, Foster MC, Eckfeldt JH, Karger AB, Nelson RG, Liu X, Sarnak M, Appel LJ, Grams M, Xie D, Kimmel PL, Feldman H, Ramachandran V, Levey AS; CKD Biomarkers Consortium.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):69-78. doi: 10.2215/CJN.03660316. Epub 2016 Nov 10.

45.

Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression.

Hsu CY, Xie D, Waikar SS, Bonventre JV, Zhang X, Sabbisetti V, Mifflin TE, Coresh J, Diamantidis CJ, He J, Lora CM, Miller ER, Nelson RG, Ojo AO, Rahman M, Schelling JR, Wilson FP, Kimmel PL, Feldman HI, Vasan RS, Liu KD; CRIC Study Investigators; CKD Biomarkers Consortium.

Kidney Int. 2017 Jan;91(1):196-203. doi: 10.1016/j.kint.2016.09.003. Epub 2016 Oct 28.

46.

Storage Time and Urine Biomarker Levels in the ASSESS-AKI Study.

Liu KD, Siew ED, Reeves WB, Himmelfarb J, Go AS, Hsu CY, Bennett MR, Devarajan P, Ikizler TA, Kaufman JS, Kimmel PL, Chinchilli VM, Parikh CR; ASSESS-AKI Study Investigators.

PLoS One. 2016 Oct 27;11(10):e0164832. doi: 10.1371/journal.pone.0164832. eCollection 2016.

47.

Comparison of trends in colorectal cancer screening in the US end-stage renal disease population and the US Medicare population.

Fwu CW, Kimmel PL, Eggers PW, Abbott KC.

Clin Kidney J. 2016 Oct;9(5):722-8. doi: 10.1093/ckj/sfw053. Epub 2016 Jun 20.

48.

Anxiety in Patients Treated with Hemodialysis.

Cohen SD, Cukor D, Kimmel PL.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2250-2255. Epub 2016 Sep 22. Review.

49.

Research Needs to Improve Hypertension Treatment and Control in African Americans.

Whelton PK, Einhorn PT, Muntner P, Appel LJ, Cushman WC, Diez Roux AV, Ferdinand KC, Rahman M, Taylor HA, Ard J, Arnett DK, Carter BL, Davis BR, Freedman BI, Cooper LA, Cooper R, Desvigne-Nickens P, Gavini N, Go AS, Hyman DJ, Kimmel PL, Margolis KL, Miller ER 3rd, Mills KT, Mensah GA, Navar AM, Ogedegbe G, Rakotz MK, Thomas G, Tobin JN, Wright JT, Yoon SS, Cutler JA; National Heart, Lung, and Blood Institute Working Group on Research Needs to Improve Hypertension Treatment and Control in African Americans.

Hypertension. 2016 Nov;68(5):1066-1072. Epub 2016 Sep 12. Review. No abstract available.

50.

Blood Pressure, Sexual Activity, and Dysfunction in Women With Hypertension: Baseline Findings From the Systolic Blood Pressure Intervention Trial (SPRINT).

Foy CG, Newman JC, Berlowitz DR, Russell LP, Kimmel PL, Wadley VG, Thomas HN, Lerner AJ, Riley WT; SPRINT Study Research Group.

J Sex Med. 2016 Sep;13(9):1333-1346. doi: 10.1016/j.jsxm.2016.06.014.

Supplemental Content

Loading ...
Support Center